2.30
price down icon15.44%   -0.42
after-market Dopo l'orario di chiusura: 2.29 -0.010 -0.43%
loading

Hookipa Pharma Inc Borsa (HOOK) Ultime notizie

pulisher
10:51 AM

Hookipa Pharma stock hits 52-week low at $2.62 amid market challenges - Investing.com

10:51 AM
pulisher
Nov 19, 2024

Companies Like HOOKIPA Pharma (NASDAQ:HOOK) Could Be Quite Risky - Simply Wall St

Nov 19, 2024
pulisher
Nov 17, 2024

HOOKIPA Pharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 17, 2024
pulisher
Nov 15, 2024

RBC Capital Mkts reiterated coverage on HOOKIPA Pharma with a new price target - Quantisnow

Nov 15, 2024
pulisher
Nov 15, 2024

HOOKIPA Pharma stock target lowered, maintains outlook on strategic direction - Investing.com UK

Nov 15, 2024
pulisher
Nov 15, 2024

HOOKIPA Pharma Inc (HOOK) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 15, 2024

Hookipa Pharma stock hits 52-week low at $3.4 amid market challenges - Investing.com Australia

Nov 15, 2024
pulisher
Nov 15, 2024

Hookipa Pharma Reports Q3 Earnings Amid Strategic Changes - TipRanks

Nov 15, 2024
pulisher
Nov 14, 2024

HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates - The Bakersfield Californian

Nov 14, 2024
pulisher
Nov 11, 2024

HOOKIPA Pharma's Eseba-vec Highlighted in SITC Late-Breaker - Quantisnow

Nov 11, 2024
pulisher
Nov 05, 2024

HOOKIPA Pharma's SWOT analysis: stock's potential in immunotherapy market - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

HOOKIPA Pharma's SWOT analysis: stock's potential in immunotherapy market By Investing.com - Investing.com UK

Nov 05, 2024
pulisher
Oct 31, 2024

HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024 - Quantisnow

Oct 31, 2024
pulisher
Oct 31, 2024

HOOKIPA commences HPV16+ cancer adjuvant care trial - Investing.com India

Oct 31, 2024
pulisher
Oct 31, 2024

HOOKIPA commences HPV16+ cancer adjuvant care trial By Investing.com - Investing.com Nigeria

Oct 31, 2024
pulisher
Oct 30, 2024

HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer - The Manila Times

Oct 30, 2024
pulisher
Oct 30, 2024

HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator - The Bakersfield Californian

Oct 30, 2024
pulisher
Oct 09, 2024

Hookipa Pharma stock hits 52-week low at $3.91 amid market challenges By Investing.com - Investing.com South Africa

Oct 09, 2024
pulisher
Oct 09, 2024

Hookipa Pharma stock hits 52-week low at $3.91 amid market challenges - Investing.com

Oct 09, 2024
pulisher
Oct 01, 2024

Hookipa Pharma stock hits 52-week low at $4.06 amid market challenges - Investing.com

Oct 01, 2024
pulisher
Sep 30, 2024

HOOKIPA Pharma's SWOT analysis: stock's potential in cancer immunotherapy - Investing.com

Sep 30, 2024
pulisher
Sep 27, 2024

HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) 26% Dip In Price Shows Sentiment Is Matching Revenues - Simply Wall St

Sep 27, 2024
pulisher
Sep 24, 2024

HOOKIPA presents KRAS cancer treatment data By Investing.com - Investing.com South Africa

Sep 24, 2024
pulisher
Sep 24, 2024

HOOKIPA presents KRAS cancer treatment data - Investing.com India

Sep 24, 2024
pulisher
Sep 24, 2024

HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset - Marketscreener.com

Sep 24, 2024
pulisher
Sep 20, 2024

Squamous Cell Carcinoma Clinical Trial Pipeline Insights: 75+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | DelveInsight - GlobeNewswire Inc.

Sep 20, 2024
pulisher
Sep 17, 2024

Kaskela Law LLC Announces Shareholder Investigation of HOOKIPA Pharma Inc. (NASDAQ: HOOK) and Encourages Investors to Contact the Firm | FinancialContent Business Page - Financial Content

Sep 17, 2024
pulisher
Sep 16, 2024

How To Trade (HOOK) - Stock Traders Daily

Sep 16, 2024
pulisher
Sep 03, 2024

Wall Street Analysts Think HOOKIPA Pharma (HOOK) Could Surge 622.75%: Read This Before Placing a Bet - MSN

Sep 03, 2024
pulisher
Aug 31, 2024

HOOKIPA appoints new Non-Executive Chair as two members exit - Investing.com India

Aug 31, 2024
pulisher
Aug 30, 2024

HOOKIPA appoints new Non-Executive Chair as two members exit By Investing.com - Investing.com South Africa

Aug 30, 2024
pulisher
Aug 30, 2024

HOOKIPA Pharma Announces Board of Directors Changes - citybiz

Aug 30, 2024
pulisher
Aug 30, 2024

Hookipa Pharma Announces Board Restructuring and Appointments - TipRanks

Aug 30, 2024
pulisher
Aug 28, 2024

HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Aug 28, 2024
pulisher
Aug 27, 2024

Hookipa Pharma Inc (NASDAQ:HOOK) Short Interest Update - MarketBeat

Aug 27, 2024
pulisher
Aug 26, 2024

Will HOOKIPA Pharma Inc. (HOOK) Report Negative Q2 Earnings? What You Should Know - MSN

Aug 26, 2024
pulisher
Aug 17, 2024

HOOK (HOOKIPA Pharma) 3-Year FCF Growth Rate : 25.90% (As of Jun. 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 15, 2024

HOOK (HOOKIPA Pharma) 3-Year Revenue Growth Rate : -34.30% (As of Jun. 2024) - GuruFocus.com

Aug 15, 2024
pulisher
Aug 13, 2024

The Market Doesn't Like What It Sees From HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) Revenues Yet As Shares Tumble 29% - Simply Wall St

Aug 13, 2024
pulisher
Aug 11, 2024

HOOKIPA Pharma Second Quarter 2024 Earnings: Revenues Miss Expectations - Yahoo Finance

Aug 11, 2024
pulisher
Aug 09, 2024

HOOK Stock Earnings: HOOKIPA Pharma Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace

Aug 09, 2024
pulisher
Aug 08, 2024

The Globe and Mail - The Globe and Mail

Aug 08, 2024
pulisher
Aug 08, 2024

HOOKHOOKIPA Pharma Inc. Latest Stock News & Market Updates - StockTitan

Aug 08, 2024
pulisher
Aug 08, 2024

SEC Form 10-Q filed by HOOKIPA Pharma Inc. - Quantisnow

Aug 08, 2024
pulisher
Aug 08, 2024

HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights - ForexTV.com

Aug 08, 2024
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Capitalizzazione:     |  Volume (24 ore):